The report " Global Permanent Birth Control drugs Market, By Drugs (Oral Contraceptives (Combined Contraceptives and Mini-pills), Contraceptive Injectable, and Topical Contraceptive Patch), By Age Group (15‐24 years, 25‐34 years, 35‐44 years, and Above 44 years), By Education (Less than high school, High school graduate, College graduate, and Other college degrees), By End User (Household, Hospitals, and Clinics), and Region - Global Forecast to 2029" Global permanent birth control drugs market is projected to grow from US$ XX billion in 2019 to US$ XX billion by 2029. The increase in the focus towards the need of family planning and preventing unintended pregnancy among the people is the major factor driving the growth of the global permanent birth control drugs market. In addition to this with the rise in higher educational attainment along with the increase in the use of contraception in young women is boosting the target market growth. Furthermore, teenage pregnancies related health issue, increase in awareness of modern contraception, and rise in use of oral pills as a key method to avoid unplanned pregnancy propel the global permanent birth control drugs market growth. However, availability of alternate contraceptive methods, health risks associated with the use of contraceptives, and lack of social acceptance are restraining the growth of permanent birth control drugs market.

Key Highlights:

• In June 2019, Pfizer Inc. declared the successful completion of its acquirement of Array BioPharma Inc.

Key Market Insights from the report:          

The global permanent birth control drugs market accounted for US$ XX billion in 2019 and is projected to register a moderate CAGR of XX% over the forecast period. The market report has been segmented on the basis of marketed drug, mechanism of action, innovator and off-label drugs and region.

• By drugs, the global permanent birth control drugs market is segmented into oral contraceptives, contraceptive injectable, and topical contraceptive patch. Oral contraceptives are further sub-divided into combined contraceptives and mini-pills. 
• By age group, the global permanent birth control drugs market is segmented into 15‐24 years, 25‐34 years, 35‐44 years, and above 44 years
• By education, the global permanent birth control drugs market is segmented into less than high school, high school graduate, college graduate, and other college degrees.
• By end-user, the global permanent birth control drugs market is subdivided into household, hospitals, and clinics
• By region, North America is having largest market in terms of revenue due to growing awareness about STDs in the US and Canada.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on " Global Permanent Birth Control drugs Market, By Drugs (Oral Contraceptives (Combined Contraceptives and Mini-pills), Contraceptive Injectable, and Topical Contraceptive Patch), By Age Group (15‐24 years, 25‐34 years, 35‐44 years, and Above 44 years), By Education (Less than high school, High school graduate, College graduate, and Other college degrees), By End User (Household, Hospitals, and Clinics), and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)- forecast till 2029

To know the upcoming trends and insights prevalent in this market, click the link below:

https://prophecymarketinsights.com/market_insight/Global-Permanent-Birth-Control-drugs-2582 

The prominent player operating in the global permanent birth control drugs market includes The Female Health Company, Allergan plc, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Cooper Companies, Inc., Mayer Laboratories, Ansell LTD., Merck & Co., Inc., and Church & Dwight, Co., Inc.